These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18413734)

  • 1. Targeted deletion of Prkar1a reveals a role for protein kinase A in mesenchymal-to-epithelial transition.
    Nadella KS; Jones GN; Trimboli A; Stratakis CA; Leone G; Kirschner LS
    Cancer Res; 2008 Apr; 68(8):2671-7. PubMed ID: 18413734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
    Stratakis CA
    Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex.
    Kirschner LS
    J Intern Med; 2009 Jul; 266(1):60-8. PubMed ID: 19522826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A.
    Pavel E; Nadella K; Towns WH; Kirschner LS
    Mol Endocrinol; 2008 Feb; 22(2):430-40. PubMed ID: 17932105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
    Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
    Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.
    Kirschner LS; Kusewitt DF; Matyakhina L; Towns WH; Carney JA; Westphal H; Stratakis CA
    Cancer Res; 2005 Jun; 65(11):4506-14. PubMed ID: 15930266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!
    Stergiopoulos SG; Stratakis CA
    FEBS Lett; 2003 Jul; 546(1):59-64. PubMed ID: 12829237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
    Kaltsas GA; Kola B; Borboli N; Morris DG; Gueorguiev M; Swords FM; Czirják S; Kirschner LS; Stratakis CA; Korbonits M; Grossman AB
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):443-8. PubMed ID: 12354125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of novel PRKAR1A mutants that extend the predicted RIα protein sequence into the 3'-untranslated open reading frame: proteasomal degradation leads to RIα haploinsufficiency and Carney complex.
    Patronas Y; Horvath A; Greene E; Tsang K; Bimpaki E; Haran M; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E496-502. PubMed ID: 22205709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation.
    Takano K; Yasufuku-Takano J; Morita K; Mori S; Takei M; Osamura RY; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2009 May; 70(5):769-75. PubMed ID: 19178533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carney complex: pathology and molecular genetics.
    Boikos SA; Stratakis CA
    Neuroendocrinology; 2006; 83(3-4):189-99. PubMed ID: 17047382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model for Carney complex.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos S; Robinson-White A; Weinberg F; Meoli E; Bornstein SR; Stratakis CA
    Endocr Res; 2004 Nov; 30(4):903-11. PubMed ID: 15666843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling.
    Almeida MQ; Muchow M; Boikos S; Bauer AJ; Griffin KJ; Tsang KM; Cheadle C; Watkins T; Wen F; Starost MF; Bossis I; Nesterova M; Stratakis CA
    Hum Mol Genet; 2010 Apr; 19(8):1387-98. PubMed ID: 20080939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins.
    Nadella KS; Kirschner LS
    Cancer Res; 2005 Nov; 65(22):10307-15. PubMed ID: 16288019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice.
    Veugelers M; Wilkes D; Burton K; McDermott DA; Song Y; Goldstein MM; La Perle K; Vaughan CJ; O'Hagan A; Bennett KR; Meyer BJ; Legius E; Karttunen M; Norio R; Kaariainen H; Lavyne M; Neau JP; Richter G; Kirali K; Farnsworth A; Stapleton K; Morelli P; Takanashi Y; Bamforth JS; Eitelberger F; Noszian I; Manfroi W; Powers J; Mochizuki Y; Imai T; Ko GT; Driscoll DA; Goldmuntz E; Edelberg JM; Collins A; Eccles D; Irvine AD; McKnight GS; Basson CT
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14222-7. PubMed ID: 15371594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRKAR1A and the evolution of pituitary tumors.
    Kirschner LS
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):3-7. PubMed ID: 20451576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.